Recombinant GM-CSF has been shown to inhibit BCa cell growth in mouse models [28,29], and when overexpressed was able to sensitize BCa cells to chemotherapeutics [30] suggesting that GM-CSF plays an anti-cancer role. This evidence concerns the gene CSF2 and cancer.